Plasma Biomarker in Amblyopia Patients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This prospective study aims to observe the predictive effect of peripheral blood plasma biomarker on the outcome of treatment in children with different types of amblyopia. We also investigated the mechanism of neuromodulation in the visual development of amblyopic children.
Epistemonikos ID: 622a24c55a8e5c542defb30a0c4fb4adc763b1b3
First added on: May 14, 2024